DOTA ≥99% CAS No: 60239-18-1
DOTA ≥99%,10-Tetraazacyclododecane-1,1,4,7,10-tetraacetic acid ≥99%
Product Name: 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)
Product Purity: ≥99%
CAS No: 60239-18-1
High-Performance DOTA Chelator

Professional Product Introduction
DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid) is a cornerstone macrocyclic polyamine carboxylic acid chelating agent. At Shaanxi Sunrise Pharmaceutical, we utilize advanced synthesis pathways to ensure DOTA with ultra-low trace metal interference. This makes it the ideal ligand for forming high-stability complexes with lanthanides and radiometals (Gd³⁺, ⁶⁸Ga, ¹⁷⁷Lu, ⁹⁰Y), supporting the most demanding applications in nuclear medicine and molecular imaging.
| CAS Number | 60239-18-1 |
| Chemical Formula | C₁₆H₂₈N₄O₈ |
| Molecular Weight | 404.41 g/mol |
| Appearance | White to off-white crystalline powder |
| HPLC Purity | ≥ 99.0% (Certified) |
| Heavy Metals | ≤ 10 ppm |
| Packaging | 1g, 5g, 10g, 100g or bulk custom |
Core Technical Advantages
Unrivaled Kinetic Stability
The "rigid cage" effect of the 12-membered ring provides superior thermodynamic stability compared to open-chain chelators (like DTPA), ensuring zero isotope leakage in physiological conditions.
Optimized Labeling Yields
Our ultra-pure grade DOTA maximizes radio-labeling efficiency, reducing the need for extensive post-labeling purification in PET/SPECT tracer production.
Bifunctional Versatility
The four acetic acid arms offer multiple coordination sites or can be activated (e.g., as NHS esters) for conjugation to peptides, antibodies, or nanoparticles.
Pharmacology & Mechanism
The performance of DOTA-based agents relies on the precise coordination of metal ions within its macrocyclic cavity:
The Coordination "Cage": DOTA acts as an octadentate ligand. The four nitrogen atoms in the ring and four carbonyl oxygens from the acetate groups form a highly stable, square-antiprismatic coordination geometry.
Radionuclide Transport: By forming an inert complex, DOTA prevents the toxic buildup of free metal ions (like Gadolinium or Lutetium) in the liver or bone, ensuring safe excretion via the kidneys.
Molecular Precision: In Theranostics, DOTA serves as the bridge, linking the diagnostic isotope (imaging) and the therapeutic isotope (treatment) to the same targeting biomolecule.


